- Home
- A
as 12-20-2024 4:00pm EST
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 40.2B | IPO Year: | 1999 |
| Target Price: | $141.93 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.43 | EPS Growth: | 5.73 |
| 52 Week Low/High: | $124.16 - $155.35 | Next Earning Date: | 11-25-2024 |
| Revenue: | $6,510,000,000 | Revenue Growth: | -4.73% |
| Revenue Growth (this year): | 7.13% | Revenue Growth (next year): | 6.45% |
Stock Insider Trading Activity of Agilent Technologies Inc. (A)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MCDONNELL PADRAIG | A | President and CEO | Sep 27 '24 | Sell | $150.00 | 47 | $7,050.00 | 24,071 |
Latest Agilent Technologies Inc. News
A Breaking Stock News: Dive into A Ticker-Specific Updates for Smart Investing
Morningstar Research
a day ago
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
Business Wire
2 days ago
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MT Newswires
4 days ago
Leerink Partners Adjusts Agilent Technologies Price Target to $155 From $150, Maintains Outperform Rating
Argus Research
4 days ago
A: Lowering target price to $143.00
Argus Research
11 days ago
A: Raising target price to $149.00
MT Newswires
11 days ago
Agilent Cancer Diagnostic Assay Receives Certification to Comply with New EU Regulations
Business Wire
12 days ago
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
Zacks
12 days ago
Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock?
Compare A vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "A Agilent Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.